Virtual

This 90-minute webinar will explore the importance of medicines as an intervention for Opioid Use Disorder (OUD), especially in rural settings. The presenter will provide a brief overview of the scope of the opioid problem and its interconnection with other substances in increasing overdose deaths as well as discuss strategies overcoming stigma faced by individuals with OUD in rural settings, medical and behavioral treatment, and strategies to prevent overdoses.

This 90-minute webinar will provide a detailed review of emerging drugs impacting non-metropolitan rural communities across the United States. Epidemiological data on synthetic drugs, fentanyl, other synthetic opioids, xylazine, cannabis, methamphetamine, cocaine, mixed opioids/stimulants, and vaping will be presented.

This 9-week online Enhanced Professional Learning (EPL) interactive series will cover topics and provide interactive practice opportunities essential to the development and/or refinement of MI skills and relational style.

Motivational interviewing (MI) is a conversational method to promote behavior change by focusing on a person’s ambivalence and intrinsic motivation. It has been extensively researched in diverse areas like substance use, diet, exercise, and medication adherence.

This workshop will highlight how to develop a virtual presence that leads to building empathy, trust, and mutual respect.

The 90-minute ethics webinar will equip behavioral health professionals with an understanding of ethical principles for application in their professional roles.

The Pacific Southwest ROTA-R will be hosting a 2-part webinar series showcasing the Healthy Living, Sustainable Recovery Fact Sheets. Please join us to learn more and ask questions about the resources!

The Pacific Southwest ROTA-R will be hosting a 2-part webinar series showcasing the Healthy Living, Sustainable Recovery Fact Sheets. Please join us to learn more and ask questions about the resources!

This presentation will examine the widespread availability and use of derived intoxicating cannabis products, including delta-8 THC, despite state and federal regulatory efforts.